Invention Application
- Patent Title: MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20
-
Application No.: US17288234Application Date: 2019-10-30
-
Publication No.: US20220089761A1Publication Date: 2022-03-24
- Inventor: Pavel Andreevich IAKOVLEV , Natalia Eugenievna PESTOVA , Arina Vitalevna ANIKINA , Anna Alexandrovna TRUDOVISHNIKOVA , Mariia Aleksandrovna SHCHEMELEVA , Nina Grachyaevna KHARATIAN , Valery Vladimirovich SOLOVYEV , Alexey Konstantinovich MISORIN , Sergei Vasilyevich DIDUK , Anna Vladimirovna EROSHOVA , Veronika Sergeevna USATOVA , Elena Andreevna KRENDELEVA , Iakov Iurevich USTIUGOV , Aleksei Aleksandrovich ALEKSANDROV , Iana Andreevna SMIRNOVA , Svetlana Vladimirovna KOSKOVA , Roman Alekseevich IVANOV , Dmitry Valentinovich MOROZOV
- Applicant: JOINT STOCK COMPANY "BIOCAD"
- Applicant Address: RU St.Petersburg
- Assignee: JOINT STOCK COMPANY "BIOCAD"
- Current Assignee: JOINT STOCK COMPANY "BIOCAD"
- Current Assignee Address: RU St.Petersburg
- Priority: RU2018138510 20181031
- International Application: PCT/RU2019/050205 WO 20191030
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/02 ; C12N15/63
Abstract:
The present invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA encoding said antibody, the corresponding expression vectors and methods of production thereof, as well as methods of treatment using said antibody.
Public/Granted literature
- US12202906B2 Monoclonal antibody that specifically binds to CD20 Public/Granted day:2025-01-21
Information query
